UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002868
Receipt number R000003498
Scientific Title Evaluation of gastrointestinal oppotunistic infections in patients using steroids
Date of disclosure of the study information 2009/12/10
Last modified on 2021/12/22 01:17:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of gastrointestinal oppotunistic infections in patients using steroids

Acronym

Evaluation of gastrointestinal opportunistic infections in patients using steroids

Scientific Title

Evaluation of gastrointestinal oppotunistic infections in patients using steroids

Scientific Title:Acronym

Evaluation of gastrointestinal opportunistic infections in patients using steroids

Region

Japan


Condition

Condition

Patients using steroids

Classification by specialty

Medicine in general Gastroenterology Clinical immunology
Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the correlation between the occurrence of gastrointestinal opportunistic infections and clinical findings

Basic objectives2

Others

Basic objectives -Others

To clarify the endoscopic findings of gastrointestinal opportunistic infections

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical data on types, consumption, Period of steroid use, underlying disease, symptoms, and usage history of immunosuppressants among the presence of gastrointestinal opportunistic infections (candidasis, Cytomegalovirus, mycobacteria)

Key secondary outcomes

Endosocpic findings of gastrointestinal opportunistic infections


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with adminstration of steroids internally or intravenously at more than 2weeks

Key exclusion criteria

Patients with history of gastric rection
Patients with HIV and HTLV-1 infection
Patients with Primary Immunodeficiency Syndrome
Patients with severe liver and renal disfancction
In cases when previous information of gastrointestinal lesion is known
Patients with anti-CMV medication and antibacterial drug with 4 weeks

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naomi Uemura

Organization

International Medical Center of Japan

Division name

Gastroenterology

Zip code


Address

1-21-1 Toyama Shinjyuku-ku Tokyo Japan

TEL

03-3202-7181

Email

gastriccarcinoma@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoyoshi Nagata

Organization

International Medical Center of Japan

Division name

Gastroenterology

Zip code


Address

1-21-1, Toyama, Shinjyuku-ku, Tokyo

TEL

03-3202-7181

Homepage URL


Email

gastriccarcinoma@yahoo.co.jp


Sponsor or person

Institute

International Medical Center of Japan

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立国際医療センター


Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 10 Month 01 Day

Date of IRB

2009 Year 09 Month 01 Day

Anticipated trial start date

2009 Year 10 Month 01 Day

Last follow-up date

2014 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 12 Month 31 Day

Date trial data considered complete

2014 Year 12 Month 31 Day

Date analysis concluded

2014 Year 12 Month 31 Day


Other

Other related information

prospective study


Management information

Registered date

2009 Year 12 Month 10 Day

Last modified on

2021 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003498


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name